Primary record
(2S,3S,4R,5S,6S)-2-{[(2S,3R,4S,5R,6R)-4,5-dihydroxy-6-(hydroxymethyl)-2-{[(2R,3S,4R,5R,6R)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy}oxan-3-yl]oxy}-6-methyloxane-3,4,5-triol
- 库存
- 550 克
- 纯度
- 98.1 %
化合物标识与属性
- PubChem CID
- 5288272
- SMILES
- C[C@H]1[C@H]([C@H]([C@@H]([C@@H](O1)O[C@@H]2[C@H]([C@H]([C@H](O[C@H]2O[C@@H]3[C@H](O[C@H]([C@@H]([C@H]3O)O)O)CO)CO)O)O)O)O)O
- Canonical SMILES
- C[C@@H]1O[C@@H](O[C@H]2[C@H](O[C@H]3[C@H](O)[C@@H](O)[C@H](O)O[C@@H]3CO)O[C@H](CO)[C@H](O)[C@@H]2O)[C@@H](O)[C@H](O)[C@@H]1O
名称与同义词
- H type 6
- 1gz9
- Fuca1-2Galb1-4Glcb
- RefChem:936621
- GlyTouCan:G61399NC
- CHEBI:62948
- Epitope ID:153555
- AC1NRB62
- 2'-O-alpha-L-fucopyranosyllactose
- alphaFuc(1-2)betaGal(1-4)betaGlc
- CHEBI:233964
- FUC-(1-2)GAL-(1-4)GLC
- G61399NC
- CID5288272
- GLC-(4-1)GAL-(2-1)FUC
- an H type VI histo-blood group antigen
- alpha-L-Fucp-(1->2)-beta-D-Galp-(1->4)-beta-D-Glcp
- J1.235.974H
- alpha-L-Fuc-(1->2)-beta-D-Gal-(1->4)-beta-D-Glc
- Q27132299
- alpha-L-fucopyranosyl-(1->2)-beta-D-galactopyranosyl-(1->4)-beta-D-glucopyranose
- alpha-L-fucosyl-(1->2)-beta-D-galactosyl-(1->4)-beta-D-glucose
- 6-deoxy-alpha-L-galactopyranosyl-(1->2)-beta-D-galactopyranosyl-(1->4)-beta-D-glucopyranose
- an alpha-L-Fuc-(1->2)-beta-D-Gal-(1->4)-beta-D-Glc derivative
- 4-O-(2-O-alpha-L-Fucopyranosyl-beta-D-galactopyranosyl)-beta-D-glucopyranose
- 4-O-[2-O-(6-Deoxy-alpha-L-galactopyranosyl)-beta-D-galactopyranosyl]-beta-D-glucopyranose
- 4-O-[2-O-(alpha-L-Fucopyranosyl)-beta-D-galactopyranosyl]-beta-D-glucopyranose
- (2S,3S,4R,5S,6S)-2-[(2S,3R,4S,5R,6R)-4,5-dihydroxy-6-(hydroxymethyl)-2-[(2R,3S,4R,5R,6R)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-6-methyloxane-3,4,5-triol
- (2S,3S,4R,5S,6S)-2-{[(2S,3R,4S,5R,6R)-4,5-dihydroxy-6-(hydroxymethyl)-2-{[(2R,3S,4R,5R,6R)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy}oxan-3-yl]oxy}-6-methyloxane-3,4,5-triol